Figure 2From: A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer Flow Diagram of literature review of Sorafenib in Second line renal cell carcinoma. Back to article page